Aveanna’s Q1 Revenue Leaps 15.9% Amid Raised 2026 Outlook: Core Metrics Signal Consistent Growth
First Quarter Revenue Climb Fuels Uplifted 2026 Guidance
Aveanna Healthcare Holdings (NASDAQ: AVAH) posted a strong start to 2026, reporting first-quarter revenue of $647.9 million—a 15.9% jump over the prior-year period. Fueled by broad segment gains, the company also delivered a net income of $41.7 million, up sharply from $5.2 million in Q1 2025. After this robust performance, Aveanna raised its full-year revenue and adjusted EBITDA guidance, signaling confidence in continued momentum across its national footprint.
Growth Evident in All Segments: PDS, HHH, and MS Show Increases
Breaking down the revenue, the Pediatric, Developmental, and Skilled Nursing (PDS) segment led growth with a $75.7 million increase. The Home Health & Hospice (HHH) and Medical Solutions (MS) divisions followed with $9.9 million and $3.2 million increases, respectively. This multi-segment boost reinforced the underlying strength of Aveanna’s portfolio, giving management the confidence to revise full-year 2026 revenue projections to a range of $2.56 - $2.58 billion (from $2.54 - $2.56 billion) and adjust EBITDA targets to $328 - $332 million (from previous $318 – $322 million).
Profitability and Margins: Adjusted EBITDA Outpaces Revenue Gains
Notably, adjusted EBITDA for Q1 2026 soared 25.2% year-over-year to $84.4 million, outpacing revenue growth and reflecting operating leverage. Operating income rose to $69.3 million, a 33.8% rise, and gross margin improved to $205.4 million (though the gross margin rate dipped to 31.7% from 32.8% last year due to higher growth in cost of revenue). The field contribution margin edged higher at 16.9% from 16.5%. These efficiencies point to resilient execution as the company scales up operations:
| Key Metric | Q1 2026 | Q1 2025 | % Change |
|---|---|---|---|
| Revenue ($M) | 647.9 | 559.2 | +15.9% |
| Net Income ($M) | 41.7 | 5.2 | +702.0% |
| Adjusted EBITDA ($M) | 84.4 | 67.4 | +25.2% |
| Operating Income ($M) | 69.3 | 51.8 | +33.8% |
| Gross Margin (%) | 31.7 | 32.8 | -1.1 pts |
| Field Contribution Margin (%) | 16.9 | 16.5 | +0.4 pts |
Elevated Guidance Reflects Sustainable Operating Strength
The company has revised its 2026 outlook, now projecting revenue between $2.56 and $2.58 billion (up from $2.54 to $2.56 billion) and adjusted EBITDA between $328 and $332 million (previously $318 to $322 million). This uptick in guidance is attributed to broad-based volume and pricing gains, alongside strategic execution in its preferred payor and government affairs segments. With the pending Family First Homecare acquisition still excluded from forecasts, even incremental synergies could add further upside later in the year.
Liquidity and Cash Flow: Near-Term Challenges, Ample Capacity
Despite the robust growth in earnings and revenue, Aveanna saw free cash flow dip negative in the quarter to $(3.78) million, after factoring in capital investments and loan repayments. However, $189.3 million in cash on hand and over $225 million in revolver capacity indicate strong overall liquidity to support ongoing investments and near-term working capital requirements. The acquisition of Family First Homecare is expected to temporarily reduce liquidity, but management maintains confidence in long-term balance sheet strength.
| Liquidity Metric | April 4, 2026 |
|---|---|
| Cash and Cash Equivalents ($M) | 189.3 |
| Borrowing Capacity (Revolver, $M) | 225.5 |
| Total Indebtedness ($M) | 1,483.4 |
| Free Cash Flow ($M, Q1) | -3.8 |
Key Takeaway: Growth Story Intact, Liquidity in Focus
Aveanna’s first-quarter results and raised 2026 guidance reveal a company with firm top- and bottom-line momentum. Ongoing investments and a large acquisition may pressure short-term cash flow, but the breadth of growth and sustained margin improvement provide a constructive backdrop. As the homecare industry evolves amid regulatory shifts and demographic tailwinds, investors may want to watch forthcoming updates on integration progress and cash generation for cues on the next leg of Aveanna’s journey.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI